TRYPTOPHAN HYDROXYLASE INHIBITORS FOR USE IN THE TREATMENT OF LIVER DISEASES

• 收藏
• 分享

专利权人:

ROIVANT SCIENCES GMBH

发明人:

PARALKAR, Vishwas,AIELLO, Robert J.

申请号：

IBIB2017/056015

公开号：

WO2018/060949A1

申请日:

2017.09.29

申请国别(地区):

WO

年份:

2018

代理人:

摘要：

The present disclosure is directed to the treatment or prevention of liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatocellular carcinoma using compounds which are inhibitors of tryptophan hydroxylase 1 (TPH1).La présente invention concerne le traitement ou la prévention de maladies du foie telles que la stéatose hépatique non alcoolique (NAFLD), la stéatohépatite non alcoolique (NASH) et le carcinome hépatocellulaire à laide de composés qui sont des inhibiteurs de la tryptophane hydroxylase 1 (TPH1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/